Results of natural history studies have shown improved outcomes for patients with C3 glomerulopathy (C3G) and primary immune complex–membranoproliferative glomerulonephritis (IC-MPGN) with proteinuria less than 0.88 or 1 g/g or proteinuria…
Pegcetacoplan Sustains Proteinuria Reduction Through 52 Weeks in C3G and IC-MPGN
